Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-21 Sale |
2021-07-23 4:48 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director |
14,629 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-31 Option Award |
2024-08-01 5:40 pm |
N/A N/A |
MCKESSON CORP | MCK | Dunsire Deborah Director |
349 | $0 | 349 (Direct) |
View |
| 2024-06-18 Option Award |
2024-06-20 2:29 pm |
N/A 2034-06-18 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
15,245 | $0 | 34,975 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-04 4:42 pm |
N/A N/A |
MCKESSON CORP | MCK | Dunsire Deborah Director |
56 | $0 | 56 (Direct) |
View |
| 2024-06-01 Exercise |
2024-06-04 4:42 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
4,000 | $0 | 12,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 2:29 pm |
N/A 2033-06-07 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
10,970 | $0 | 26,840 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:23 pm |
N/A 2033-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:08 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 1:48 pm |
N/A 2032-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
9,545 | $0 | 22,115 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:10 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-09-09 Option Award |
2021-09-10 5:30 pm |
N/A 2031-09-08 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-28 6:25 pm |
N/A 2031-06-24 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
6,270 | $0 | 16,695 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 4:27 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director |
2,495 | $0 | 14,629 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:10 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
6,800 | $0 | 14,675 (Direct) |
View |
| 2020-05-14 Option Award |
2020-05-18 5:10 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director |
4,409 | $0 | 12,134 (Direct) |
View |